Investors
Corporate Profile
Ocugen, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing gene therapies, biologicals and vaccines that improve health and offer hope for people and global communities. We are making an impact through courageous innovation, taking science in new directions in service of patients. Our breakthrough modifier gene therapy platform has the potential to treat multiple diseases with one drug and we are advancing research in other therapeutic areas to offer new options for people with unmet medical needs.
Ocugen News
Corporate Presentation
Events
H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference August 17, 2022 at 7:00 AM EDT
Ocugen Inc Second Quarter 2022 Financial Results and Recent Business Highlights August 5, 2022 at 8:30 AM EDT